1. Phathom Pharmaceuticals Announces Leadership Succession Plan and Strengthens Board of Directors with New Appointments

    Phathom Pharmaceuticals Announces Leadership Succession Plan and Strengthens Board of Directors with New Appointments

    She has also been appointed to Phathom's Board of Directors . Ms. Curran will succeed David Socks as part of a planned transition. Mr. Socks will ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. We are thrilled that Terrie will be joining Phathom as CEO. She is a widely respected biopharmaceutical leader with an impressive track record of building organizations and commercializing novel therapeutics, including the launch and global growth of OTEZLA®.
    2. Phathom is well positioned with vonoprazan, a late-stage GI therapeutic, that has achieved clinical and commercial success in Japan.
  3. Topics Mentioned